共 50 条
An Update on New and Existing Treatments for the Management of Melasma
被引:7
|作者:
Gan, Christian
[1
]
Rodrigues, Michelle
[2
,3
,4
]
机构:
[1] St Vincents Hosp, Dept Dermatol, Melbourne, Vic, Australia
[2] Royal Childrens Hosp, Dept Dermatol, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia
[4] Pigment & Skin Colour Ctr, Chroma Dermatol, Melbourne, Vic, Australia
关键词:
20-PERCENT AZELAIC ACID;
ORAL TRANEXAMIC ACID;
INTENSE PULSED-LIGHT;
SWITCHED NDYAG LASER;
NM FRACTIONAL PHOTOTHERMOLYSIS;
GLYCOLIC ACID;
DOUBLE-BLIND;
SPLIT-FACE;
4-PERCENT HYDROQUINONE;
THERAPEUTIC-EFFICACY;
D O I:
10.1007/s40257-024-00863-2
中图分类号:
R75 [皮肤病学与性病学];
学科分类号:
100206 ;
摘要:
Melasma is a chronic, acquired disorder of focal hypermelanosis that carries significant psychosocial impact and is challenging for both the patient and the treating practitioner to manage in the medium to long term. Multiple treatments have been explored, often in combination given the many aetiological factors involved in its pathogenesis. Therapeutic discoveries to treat melasma are a focal topic in the literature and include a range of modalities, with recent developments including updates on visible light photoprotection, non-hydroquinone depigmenting agents, oral tranexamic acid, chemical peels, and laser and energy-based device therapy for melasma. It is increasingly important yet challenging to remain up-to-date on the arsenal of treatments available for melasma to find an efficacious and well-tolerated option for our patients.
引用
收藏
页码:717 / 733
页数:17
相关论文